Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Oct 31:6:258.
doi: 10.1186/1471-2407-6-258.

Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population

Sue Wilson  1 , Michael J O Wakelam, Richard F D Hobbs, Angela V Ryan, Janet A Dunn, Val D Redman, Fiona Patrick, Lynne Colbourne, Ashley Martin, Tariq Ismail
Affiliations

Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population

Sue Wilson et al. BMC Cancer. .

Abstract

Background: Bowel cancer is common and is a major cause of death. Meta-analysis of randomised controlled trials estimates that screening for colorectal cancer using faecal occult blood (FOB) test reduces mortality from colorectal cancer by 16%. However, FOB testing has a low positive predictive value, with associated unnecessary cost, risk and anxiety from subsequent investigation, and is unacceptable to a proportion of the target population. Increased levels of an enzyme called matrix metalloproteinase 9 (MMP-9) have been found to be associated with colorectal cancer, and this can be measured from a blood sample. Serum MMP-9 is potentially an accurate, low risk and cost-effective population screening tool. This study aims to evaluate the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population.

Methods/design: People aged 50 to 69 years, who registered in participating general practices in the West Midlands Region, will be asked to complete a questionnaire that asks about symptoms. Respondents who describe any colorectal symptoms (except only abdominal bloating and/or anal symptoms) and are prepared to provide a blood sample for MMP9 estimation and undergo a colonoscopy (current gold standard investigation) will be recruited at GP based clinics by a research nurse. Those unfit for colonoscopy will be excluded. Colonoscopies will be undertaken in dedicated research clinics. The accuracy of MMP-9 will be assessed by comparing the MMP-9 level with the colonoscopy findings, and the combination of factors (e.g. symptoms and MMP-9 level) that best predict a diagnosis of malignancy (invasive disease or polyps) will be determined.

Discussion: Colorectal cancer is a major cause of morbidity and mortality. Most colorectal cancers arise from adenomas and there is a period for early detection by screening, but available tests have risks, are unacceptable to many, have high false positive rates or are expensive. This study will establish the potential of serum MMP-9 as a screening test for colorectal cancer. If it is confirmed as accurate and acceptable, this serum marker has the potential to assist with reducing the morbidity and mortality from colorectal cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Research plan and study design.
See this image and copyright information in PMC

References

    1. National Cancer Intelligence Centre Registrations of new cases of cancer diagnosed in England in by age group and sex. Rates per 100,000 population of new cases of cancer diagnosed in England in 2000, by age group and sex http://www.statistics.gov.uk/STATBASE/ssdataset.asp?vInk=6989 Accessed 21 January 2004.
    1. National Cancer Intelligence Centre Deaths, 2001 registrations: Death by age, sex and underlying cause http://www.statistics.gov.uk/StatBase/xsdataset.asp?vlnk=5670&Pos=1&ColR... Accessed 22 January 2004.
    1. National Cancer Intelligence Centre Five-year age-standardised relative survival (%) for adult patients diagnosed during 1991–95 and 1996–99, major cancers by sex, England and Wales http://www.statistics.gov.uk/StatBase/ssdataset.asp?vlnk=7091&Pos=3&ColR... Accessed 2 February 2004.
    1. National Cancer Institute Colon and rectum cancer (invasive). Survival rates, by race, sex, diagnosis, year, stage and age http://seer.cancer.gov/cgi-bin/csr/search.pl Accessed 18 February 2004.
    1. Chen C-D, Yen M-F, Wang W-M, Wong J-M, Chen TH-H. A case-cohort study for the disease natural history of adenoma-carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy. British Journal of Cancer. 2003;88:1866–1873. doi: 10.1038/sj.bjc.6601007. - DOI - PMC - PubMed

Publication types

Substances